Feiyan Chen

929 total citations
42 papers, 587 citations indexed

About

Feiyan Chen is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Feiyan Chen has authored 42 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Pharmacology and 9 papers in Oncology. Recurrent topics in Feiyan Chen's work include Ginseng Biological Effects and Applications (10 papers), Pharmacological Effects of Natural Compounds (8 papers) and Chromatography in Natural Products (4 papers). Feiyan Chen is often cited by papers focused on Ginseng Biological Effects and Applications (10 papers), Pharmacological Effects of Natural Compounds (8 papers) and Chromatography in Natural Products (4 papers). Feiyan Chen collaborates with scholars based in China, Macao and United States. Feiyan Chen's co-authors include Yucui Jiang, Weiping Chen, Yunshan Wang, Lei Bi, Yunan Zhao, Fangming Jin, Zhibao Huo, Guodong Yao, Cunsi Shen and Maoxiao Feng and has published in prestigious journals such as Cancer Research, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Feiyan Chen

34 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feiyan Chen China 15 308 102 81 54 42 42 587
Lianggong Zhao China 14 339 1.1× 108 1.1× 93 1.1× 49 0.9× 36 0.9× 27 668
Jingjing Lin China 16 334 1.1× 89 0.9× 115 1.4× 71 1.3× 41 1.0× 41 625
Xin Shen China 15 259 0.8× 98 1.0× 80 1.0× 92 1.7× 37 0.9× 50 713
Yuan-Ching Chang Taiwan 11 256 0.8× 89 0.9× 98 1.2× 49 0.9× 75 1.8× 15 787
Pooja Patni India 6 338 1.1× 116 1.1× 85 1.0× 37 0.7× 21 0.5× 6 632
Maryam Nakhjavani Australia 15 353 1.1× 114 1.1× 95 1.2× 97 1.8× 67 1.6× 37 605
Rishi K. Gara India 12 323 1.0× 84 0.8× 98 1.2× 34 0.6× 37 0.9× 12 594
Weiping Zheng China 12 266 0.9× 72 0.7× 49 0.6× 45 0.8× 50 1.2× 24 619

Countries citing papers authored by Feiyan Chen

Since Specialization
Citations

This map shows the geographic impact of Feiyan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiyan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiyan Chen more than expected).

Fields of papers citing papers by Feiyan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feiyan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiyan Chen. The network helps show where Feiyan Chen may publish in the future.

Co-authorship network of co-authors of Feiyan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Feiyan Chen. A scholar is included among the top collaborators of Feiyan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feiyan Chen. Feiyan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Yucui, Yun Huang, Feiyan Chen, et al.. (2025). Dual function of MrgprB2 receptor-dependent neural immune axis in chronic pain. Journal of Advanced Research. 78. 607–621.
2.
Gu, Ling, et al.. (2025). Identification of Prolyl endopeptidase as a novel anti-depression target of Genipin-1-b-D-gentiobioside in brain tissues. Behavioural Brain Research. 484. 115511–115511. 1 indexed citations
3.
Wang, Yu, Tinglin Zhang, Qiao Wen, et al.. (2025). Enhancing bone healing through immunological microenvironment modulation via a smart-responsive multifunctional therapeutic system. Composites Part B Engineering. 297. 112252–112252. 4 indexed citations
4.
Zhang, Hantao, Qianlin Li, Tiantian Wang, et al.. (2025). Long‐Term Creatine Supplementation Improves Cognitive and Hippocampal Structural Plasticity Impairments in a D‐Gal‐Induced Aging Model via Increasing CK‐BB Activity in the Brain. Food Science & Nutrition. 13(1). e4767–e4767. 1 indexed citations
5.
Chen, Feiyan, Wenjing Zhang, Hong You, et al.. (2025). 20(S)-protopanaxadiol targets brain-enriched adenylate kinase 5 to improve cognitive function via regulating hippocampal neural plasticity. Phytomedicine. 150. 157711–157711.
6.
Chen, Cuihua, Ling Gu, Lisi Zou, et al.. (2025). Identification of PFN2 as an Epimedii Folium flavonoid brain target by mass spectrometry in conjunction with DRATS. South African Journal of Botany. 184. 26–39.
7.
Yang, Lili, Feiyan Chen, Yao Chen, et al.. (2025). Ginsenoside compound K ameliorates depressive-like behaviors by targeting kynurenine 3-monooxygenase. Phytomedicine. 148. 157335–157335.
8.
Chen, Cuihua, et al.. (2024). Genetic diversity in halophyte Apocyni Veneti Folium (Apocynum venetum L.) provides insights into candidate gene mining. South African Journal of Botany. 167. 108–121.
9.
Wang, Yu, et al.. (2024). Exploring the frontiers: The potential and challenges of bioactive scaffolds in osteosarcoma treatment and bone regeneration. Materials Today Bio. 29. 101276–101276. 13 indexed citations
11.
Chen, Feiyan, Wenjing Zhang, Hantao Zhang, et al.. (2023). Discovery and validation of PURA as a transcription target of 20(S)-protopanaxadiol: Implications for the treatment of cognitive dysfunction. Journal of Ginseng Research. 47(5). 662–671. 7 indexed citations
13.
Bi, Lei, Yidan Ren, Maoxiao Feng, et al.. (2021). HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness. Cancer Research. 81(8). 2015–2028. 123 indexed citations
14.
Chen, Lin, Feiyan Chen, Hantao Zhang, et al.. (2021). A possible mechanism to the antidepressant-like effects of 20 (S)-protopanaxadiol based on its target protein 14-3-3 ζ. Journal of Ginseng Research. 46(5). 666–674. 7 indexed citations
16.
Lin, Zixuan, Feiyan Chen, Jianguo Dai, et al.. (2020). Structure-activity relationship analysis of dammarane-type natural products as muscle-type creatine kinase activators. Bioorganic & Medicinal Chemistry Letters. 30(17). 127364–127364. 6 indexed citations
17.
Chen, Feiyan, Lin Chen, Jiao Li, et al.. (2020). Identification and confirmation of 14-3-3 ζ as a novel target of ginsenosides in brain tissues. Journal of Ginseng Research. 45(4). 465–472. 15 indexed citations
18.
Chen, Cuihua, Jiali Chen, Jingjing Shi, et al.. (2019). A strategy for quality evaluation of salt-treated Apocyni Veneti Folium and discovery of efficacy-associated markers by fingerprint-activity relationship modeling. Scientific Reports. 9(1). 16666–16666. 11 indexed citations
19.
Zhao, Yunan, et al.. (2018). Hippocampal astrocyte atrophy in a mouse depression model induced by corticosterone is reversed by fluoxetine instead of benzodiazepine diazepam. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 83. 99–109. 26 indexed citations
20.
Du, Yongzhong, Cai, Li Li, et al.. (2011). Receptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles. International Journal of Nanomedicine. 6. 1559–1559. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026